Two cancer drugs have been approved for patients on the NHS in Scotland. An immunotherapy for some people with advanced skin cancer and a targeted drug for some patients with breast cancer got the green light this week. Pembrolizumab (Keytruda) will now be an option for patients whose melanoma has spread to the lymph nodes and who have already had surgery.
Read more at: https://www.cancerresearchuk.org/about-us/cancer-news/news-report/2019-05-16-skin-and-breast-cancer-drugs-approved-for-nhs-use-in-scotland
